Challenges in Embolic Stroke: Deciding Between Combination Medical and PFO Closure or Medical Management Alone With Drs. Howard Herrmann and John Carroll

Challenges in Embolic Stroke: Embolic Stroke Treatment With Drs. Howard Herrmann and John Carroll

Challenges in Embolic Stroke: Getting With the Guidelines – PFO Closure and the Use of Medical Therapy With Drs. Howard Herrmann and Scott Kasner

Challenges in Embolic Stroke: Confronting Challenges in Diagnosis With Drs. Howard Herrmann and Scott Kasner

PFO Closure: Procedural Pearls and Important Considerations with Drs. Herrmann, Carroll, and Kasner

Managing Patients With Cryptogenic Stroke: Clinical Perspectives, with Drs. Herrmann, Carroll, and Kasner

The Relationship Between PFO and Cryptogenic Stroke: Reviewing the Data, with Drs. Herrmann, Carroll, and Kasner

Diagnosis and Classification of Cryptogenic Stroke and PFO-Associated Stroke, with Drs. Herrmann, Carroll, and Kasner

Recent Cardiovascular Outcomes Trials: Reducing Triglycerides for Further Risk Reduction with Drs. Pamela Morris and Deepak Bhatt

Deep Dive Into Clinical Evidence: Reducing CVD risk through LDL-C reduction with Drs. Pamela Morris and Ann Marie Navar

Patient Identification for Residual Risk Management: Who’s At Risk? with Drs. Pamela Morris and Martha Gulati

Strategies for Atherosclerotic Cardiovascular Disease (ASCVD) Risk Assessment: What’s the Risk? with Drs. Pamela Morris and Martha Gulati

sGC Modulators: Role in Current Treatment Paradigms for Heart Failure With Drs. Paul Armstrong and Javed Butler

The Clinical Evidence: Efficacy and Safety of sGC Modulators in Heart Failure With Reduced Ejection Fraction With Drs. Paul Armstrong and Javed Butler

sGC Modulators: Unique Mechanism of Action and Rationale for Use in Heart Failure With Drs. Paul Armstrong and Carolyn Lam

Heart Failure Management: Guideline-directed Therapy and Unmet Needs With Drs. Paul Armstrong and Carolyn Lam

Cardiovascular Risk Reduction in Patients with Diabetes: Coordinating Efforts Between Cardiologists and Endocrinologists; Blood Pressure Control and Optimizing Care Coordination and Medication Management

Cardiovascular Risk Reduction in Patients with Diabetes: Coordinating Efforts Between Cardiologists and Endocrinologists; Reducing CV Risk in Patients With Diabetes – A Discussion on the Latest Data

Cardiovascular Risk Reduction in Patients with Diabetes: Coordinating Efforts Between Cardiologists and Endocrinologists; The Interplay Between T2DM and CV Risk – Implications for Patients

MedEd Talks in Cardiology - Cardiovascular Risk Reduction in Patients with Diabetes: Coordinating Efforts Between Cardiologists and Endocrinologists